Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2010
Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cellsJ C Carter, R A Campbell, J A Gibbons, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 21, 2009
Cross-species comparisons of the pharmacokinetics of ibudilastL M Sanftner, J A Gibbons, M I Gross, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptorsJ A Gibbons, A A Hancock, C R Vitt, et al.The Veterinary Record|October 10, 2003
Prevalence of faecal excretion of verocytotoxigenic Escherichia coli O157 in cattle in England and WalesG A Paiba, J W Wilesmith, S J Evans, et al.Nature Biotechnology|November 4, 2000
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivoA B Shanafelt, Y Lin, M C Shanafelt, et al.Pageof 3